Crystal structure of the non-steroidal anti-inflammatory drug (NSAID) tolmetin sodium

Por Konovalova, Irina S., Kovalenko, Sergiy M., Kravchenko, Dmitry V., Chuev, Vladimir P.
Publicado no Acta Crystallogr E Crystallogr Commun (2021)

(1R,3S)-3-(1H-Benzo[d]imidazol-2-yl)-1,2,2-tri­methyl­cyclo­pentane-1-carb­oxy­lic acid as a new anti-diabetic active pharmaceutical ingredient

Por Kovalenko, Sergiy M., Konovalova, Irina S., Merzlikin, Sergiy I., Chuev, Vladimir P., Kravchenko, Dmitry V.
Publicado no Acta Crystallogr E Crystallogr Commun (2020)

Crystal structure, Hirshfeld analysis and a mol­ecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxa­diazo...

Por Ivachtchenko, Alexandre V., Kovalenko, Sergiy M., Kravchenko, Dmitry V., Mitkin, Oleg D., Ivanov, Vladimir V., Langer, Thierry
Publicado no Acta Crystallogr E Crystallogr Commun (2020)

Synthesis, X-ray crystal structure, Hirshfeld surface analysis, and molecular docking study of novel inhibitor of hepatitis B: methyl 4-fluoro-3-(morpholinosulfonyl)benzo[b]thiophe...

Por Ivachtchenko, Alexandre V., Mitkin, Oleg D., Kravchenko, Dmitry V., Kovalenko, Sergiy M., Shishkina, Svitlana V., Bunyatyan, Natalya D., Konovalova, Irina S., Dmitrieva, Irina G., Ivanov, Vladimir V., Langer, Thierry
Publicado no Heliyon (2019)

Methylation of Methyl 4-Hydroxy-2-thioxo-1,2-dihydroquinoline-3-carboxylate: Synthetic, Crystallographic, and Molecular Docking Studies

Por Kovalenko, Sergiy M., Drushlyak, Oleksandr G., Shishkina, Svitlana V., Konovalova, Irina S., Mariutsa, Illia O., Bunyatyan, Natalya D., Kravchenko, Dmitry V., Ivanov, Vladimir V., Ivachtchenko, Alexandre V., Langer, Thierry
Publicado no Molecules (2020)

Preclinical Development of ONC1-13B, Novel Antiandrogen for Prostate Cancer Treatment

Por Ivachtchenko, Alexandre V., Mitkin, Oleg D., Kudan, Elizaveta V., Rjahovsky, Alexey A., Vorobiev, Anton A., Trifelenkov, Andrey S., Shevkun, Natalia A., Proskurina, Oxana V., Kravchenko, Dmitry V., Karapetian, Ruben N.
Publicado em 2014

Synthesis, inhibitory activity and oral dosing formulation of AV5124, the structural analogue of influenza virus endonuclease inhibitor baloxavir

Por Ivashchenko, Andrei A, Mitkin, Oleg D, Jones, Jeremy C, Nikitin, Alexander V, Koryakova, Angela G, Karapetian, Ruben N, Kravchenko, Dmitry V, Mochalov, Stephan V, Ryakhovskiy, Alexey A, Aladinskiy, Vladimir, Leneva, Irina A, Falynskova, Irina N, Glubokova, Ekaterina A, Govorkova, Elena A, Ivachtchenko, Alexandre V
Publicado no J Antimicrob Chemother (2020)

AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial

Por Ivashchenko, Andrey A, Dmitriev, Kirill A, Vostokova, Natalia V, Azarova, Valeria N, Blinow, Andrew A, Egorova, Alina N, Gordeev, Ivan G, Ilin, Alexey P, Karapetian, Ruben N, Kravchenko, Dmitry V, Lomakin, Nikita V, Merkulova, Elena A, Papazova, Natalia A, Pavlikova, Elena P, Savchuk, Nikolay P, Simakina, Elena N, Sitdekov, Tagir A, Smolyarchuk, Elena A, Tikhomolova, Elena G, Yakubova, Elena V, Ivachtchenko, Alexandre V
Publicado no Clin Infect Dis (2020)